FranΓ§aisπ See the interactive version (live chart) β
For Adient, we replayed every analyst price target of the past 12 months and measured the real outcome: 30% were profitable, average return +1% (100 calls). At 3 months: -1% average return (39% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Morgan Stanley | 23 | 39% | +0% |
| Wells Fargo | 20 | 10% | -21% |
| Barclays | 12 | 8% | -19% |
| B of A Securities | 11 | 9% | -35% |
| Keybanc | 7 | 71% | +27% |
The analyst consensus on Adient (ADNT) is "Buy" (21 bullish, 1 bearish calls over 12 months). This is not advice: historically, 30% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $28.50 (+51% vs $18.83), ranging from $21.00 to $32.00 (8 analysts).
Over 1 year, 30% of analyst targets on Adient were profitable, for an average return of +1% (across 100 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $28.50 within 12 months, i.e. +51% vs the current price. The most bullish targets $32.00, the most cautious $21.00.
Note: analyst targets are 12-month (median $28.50, +51%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (30%), and the stock's past trajectory.
Detailed valuation data for Adient is available in the interactive analysis.
π See the full interactive analysis of Adient β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.